Stay updated on Expanded Access to Upadacitinib Clinical Trial
Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated from v3.5.5 to v3.6.0. New navigation entries such as 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added to help users access guidance.SummaryDifference0.7%

- Check19 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, signaling a new version of the record. It appears to be a metadata update rather than a substantive change to the study information.SummaryDifference0.1%

- Check41 days agoChange DetectedUpdated the study record's revision from v3.5.3 to v3.5.4, reflecting an administrative update to the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page shows a new revision identifier (v3.5.3) replacing v3.5.2. This indicates a minor update to the page (likely formatting or backend fixes) without changing study details.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.5.2. This appears to be a maintenance/version update with no visible changes to study details or user-facing content.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.